Product image of Zolsketil Pegylated Liposomal (Doxorubicin Hydrochloride, Liposomal) supplied by GNH India

Zolsketil Pegylated Liposomal

Active Ingredient:
Doxorubicin Hydrochloride, Liposomal
Origin:
EU

Zolsketil Pegylated Liposomal (Doxorubicin Hydrochloride, Liposomal)

Zolsketil Pegylated Liposomal is a specialized injectable formulation designed for targeted delivery in certain cancer treatments. This liposomal doxorubicin variant enhances drug stability and reduces off-target effects. Ideal for oncology protocols requiring pegylated liposomal technology.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zolsketil Pegylated Liposomal is used in medical settings for the treatment of specific cancers, including metastatic breast cancer and ovarian cancer when conventional therapies are unsuitable. It may also be prescribed for advanced Kaposi’s sarcoma in immunocompromised patients. This formulation is designed for intravenous administration under clinical supervision.

Side Effects

  • The medication works by delivering doxorubicin directly to cancer cells while minimizing exposure to healthy tissues. Patients may experience gradual symptom relief as part of their treatment plan. The liposomal carrier system helps sustain drug levels in the bloodstream for extended therapeutic activity.

Precautions & Warnings

  • This medication should only be handled and administered by healthcare professionals in a controlled clinical environment. Proper aseptic technique is required to prevent contamination. Patients should report any signs of infection, unusual bleeding, or severe fatigue immediately. Regular monitoring of cardiac and hematologic function is advised during therapy.

Avoid Interactions

  • Concurrent use with other cardiotoxic drugs may increase the risk of heart-related side effects. Strong CYP3A4 inhibitors can alter drug metabolism, potentially affecting efficacy or toxicity. Patients should inform their provider about all medications, including over-the-counter and herbal supplements. Alcohol consumption should be avoided during treatment.

Frequently Asked Questions

It is used to treat certain cancers like metastatic breast cancer, ovarian cancer, and Kaposi’s sarcoma when standard treatments are not suitable.

This medication is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects may include fatigue, nausea, and changes in blood cell counts, which are typically monitored during treatment.

Always consult your healthcare provider before combining this drug with other medications, as interactions may occur.

This medication is prescribed based on individual health assessments and should only be used under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Doxorubicin Hydrochloride, Liposomal

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT